✦ LIBER ✦

Studies on the potential use of CD38 expression as a marker for the efficacy of anti-retroviral therapy in HIV-1-infected patients in Thailand

✍ Scribed by Nattawat Onlamoon; Sutchana Tabprasit; Surapol Suwanagool; Suda Louisirirotchanakul; Aftab A. Ansari; Kovit Pattanapanyasat

Book ID: 113946487
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 462 KB
Volume: 341
Category: Article
ISSN: 0042-6822
DOI: 10.1016/j.virol.2005.07.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of interleukin-2 on the pool of l

Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

✍ Chun, Tae-Wook; Engel, Delphine; Mizell, Stephanie B.; Hallahan, Claire W.; Fisc 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

CD38 expression on CD8 T cells has a wea

CD38 expression on CD8 T cells has a weak association with CD4 T-cell recovery and is a poor marker of viral replication in HIV-1-infected patients on antiretroviral therapy

✍ A Steel; L John; MH Shamji; DC Henderson; FM Gotch; BG Gazzard; P Kelleher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

Effects of potent antiretroviral therapy

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A–D

✍ Ann Atlas; Tran Thi Thanh Ha; Anna Lindström; Anna Nilsson; Annette Alaeus; Fran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract HIV‐1 genetic subtypes might have a different impact on disease progression and response to antiretroviral therapy (ART). Few data are available on the immune activation profile in patients with different HIV‐1 subtypes. We have tested by ELISA the plasma levels of an immune activation

CD4 Expressing Human 293 Cells as a Tool

CD4 Expressing Human 293 Cells as a Tool for Studies in HIV-1 Replication: The Efficiency of Translational Frameshifting Is Not Altered by HIV-1 Infection

✍ Heide Reil; Maria Höxter; Dieter Moosmayer; Georg Pauli; Hansjörg Hauser 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 293 KB

A pilot study of the safety and efficacy

A pilot study of the safety and efficacy of thymosin α1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy

✍ D. CHADWICK; J. PIDO-LOPEZ; A. PIRES; N. IMAMI; F. GOTCH; J. S. VILLACIAN; S. RA 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB